Literature DB >> 10552021

MRI of Wolfram syndrome (DIDMOAD).

P Galluzzi1, G Filosomi, I M Vallone, A M Bardelli, C Venturi.   

Abstract

Wolfram syndrome (DIDMOAD) is a rare diffuse neurodegenerative disorder characterised by diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and a wide variety of abnormalities of the central nervous system, urinary tract and endocrine glands. It may be familial or sporadic. Reported features on MRI of the brain are absence of the physiological high signal of the posterior lobe of the pituitary, shrinkage of optic nerves, chiasm and tracts, atrophy of the hypothalamic region, brain stem, cerebellum, and cerebral cortex. We report a 12-year-old girl with a 5-year history without brain stem, cerebellar or cerebral atrophy. MRI showed an unusual feature: a focus of high signal on PD- and T2-weighted images in the right substantia nigra. This is consistent with previously reported neuropathological post-mortem studies, but has never been reported in vivo.

Entities:  

Mesh:

Year:  1999        PMID: 10552021     DOI: 10.1007/s002340050832

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  11 in total

1.  Balance impairment in individuals with Wolfram syndrome.

Authors:  Kristen A Pickett; Ryan P Duncan; Alex R Paciorkowski; M Alan Permutt; Bess Marshall; Tamara Hershey; Gammon M Earhart
Journal:  Gait Posture       Date:  2012-07-06       Impact factor: 2.840

Review 2.  Endocrine and metabolic aspects of the Wolfram syndrome.

Authors:  Georgios Boutzios; Sarantis Livadas; Evangelos Marinakis; Nicole Opie; Frangiskos Economou; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2011-08       Impact factor: 3.633

3.  Longitudinal Assessment of Neuroradiologic Features in Wolfram Syndrome.

Authors:  A Samara; H M Lugar; T Hershey; J S Shimony
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-29       Impact factor: 3.825

4.  Wolfram syndrome: a clinicopathologic correlation.

Authors:  Justin B Hilson; Saumil N Merchant; Joe C Adams; Jeffrey T Joseph
Journal:  Acta Neuropathol       Date:  2009-05-16       Impact factor: 17.088

5.  Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.

Authors:  Agnieszka Zmyslowska; Bogdan Malkowski; Wojciech Fendler; Maciej Borowiec; Karolina Antosik; Piotr Gnys; Dobromila Baranska; Wojciech Mlynarski
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

6.  Diabetes mellitus, diabetes insipidus, optic atrophy, and deafness: A case of Wolfram (DIDMOAD) syndrome.

Authors:  Nasrollah Maleki; Bahman Bashardoust; Anahita Zakeri; Azita Salehifar; Zahra Tavosi
Journal:  J Curr Ophthalmol       Date:  2016-01-02

7.  Knockdown of wfs1, a fly homolog of Wolfram syndrome 1, in the nervous system increases susceptibility to age- and stress-induced neuronal dysfunction and degeneration in Drosophila.

Authors:  Yasufumi Sakakibara; Michiko Sekiya; Naoki Fujisaki; Xiuming Quan; Koichi M Iijima
Journal:  PLoS Genet       Date:  2018-01-22       Impact factor: 5.917

8.  Early brain vulnerability in Wolfram syndrome.

Authors:  Tamara Hershey; Heather M Lugar; Joshua S Shimony; Jerrel Rutlin; Jonathan M Koller; Dana C Perantie; Alex R Paciorkowski; Sarah A Eisenstein; M Alan Permutt
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

9.  Impairment of visual function and retinal ER stress activation in Wfs1-deficient mice.

Authors:  Delphine Bonnet Wersinger; Nesrine Benkafadar; Jolanta Jagodzinska; Christian Hamel; Yukio Tanizawa; Guy Lenaers; Cécile Delettre
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

10.  A novel CISD2 intragenic deletion, optic neuropathy and platelet aggregation defect in Wolfram syndrome type 2.

Authors:  Enza Mozzillo; Maurizio Delvecchio; Massimo Carella; Elvira Grandone; Pietro Palumbo; Alessandro Salina; Concetta Aloi; Pietro Buono; Antonella Izzo; Giuseppe D'Annunzio; Gennaro Vecchione; Ada Orrico; Rita Genesio; Francesca Simonelli; Adriana Franzese
Journal:  BMC Med Genet       Date:  2014-07-24       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.